The University of Chicago Header Logo

Long-term Relugolix Combination Therapy for Symptomatic Uterine Leiomyomas.

Long-term Relugolix Combination Therapy for Symptomatic Uterine Leiomyomas. Obstet Gynecol. 2022 12 01; 140(6):920-930.

View in: PubMed